2. Academic Validation
  3. Novel Pyrazolopyrazine Compounds as SHP2 Inhibitors for Treating Glioblastoma

Novel Pyrazolopyrazine Compounds as SHP2 Inhibitors for Treating Glioblastoma

  • ACS Med Chem Lett. 2023 Sep 19;14(10):1336-1337. doi: 10.1021/acsmedchemlett.3c00393.
Ram W Sabnis 1
Affiliations

Affiliation

  • 1 Smith, Gambrell & Russell LLP, 1105 W. Peachtree Street NE, Suite 1000, Atlanta, Georgia 30309, United States.
PMID: 37849559 DOI: 10.1021/acsmedchemlett.3c00393
Abstract

Provided herein are novel pyrazolopyrazine compounds as SHP2 inhibitors, pharmaceutical compositions, use of such compounds in treating glioblastoma, and processes for preparing such compounds.

Figures
Products